Clinical Trial Update: Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

View source ↗

Summary

This clinical trial update describes the performance of the PEAR 2.0 software in prescribing biotherapy for rheumatoid arthritis; the study NCT06186375 is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: CEN Biotech | Conditions: Polyarthritis; Rheumatoid | Status: ACTIVE_NOT_RECRUITING